Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Current Assets (2018 - 2025)

Historic Current Assets for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to $20.2 billion.

  • Takeda Pharmaceutical's Current Assets rose 1175.62% to $20.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $20.2 billion, marking a year-over-year increase of 1175.62%. This contributed to the annual value of $16.6 billion for FY2025, which is 670.89% down from last year.
  • According to the latest figures from Q4 2025, Takeda Pharmaceutical's Current Assets is $20.2 billion, which was up 1175.62% from $19.8 billion recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Current Assets ranged from a high of $25.6 billion in Q1 2021 and a low of $16.4 billion during Q4 2023
  • Its 5-year average for Current Assets is $19.6 billion, with a median of $19.8 billion in 2022.
  • Its Current Assets has fluctuated over the past 5 years, first tumbled by 1877.17% in 2023, then surged by 2009.65% in 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Current Assets (Quarter) stood at $21.8 billion in 2021, then decreased by 15.71% to $18.4 billion in 2022, then dropped by 10.58% to $16.4 billion in 2023, then grew by 10.26% to $18.1 billion in 2024, then increased by 11.76% to $20.2 billion in 2025.
  • Its Current Assets was $20.2 billion in Q4 2025, compared to $19.8 billion in Q3 2025 and $17.4 billion in Q2 2025.